Discovery Capital Management Portfolio holdings

Discovery Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Discovery Capital Management held 135 positions worth $6.91B, down 18% from $8.44B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Discovery Capital Management withdrew a net $1.74B in Q1 2016, closing 37 positions and reducing 18 holdings. Its most notable exit was Pfizer, an estimated $471M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, down from 20% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Discovery Capital Management opened a new position in iShares MSCI Emerging Markets ETF worth $426M.

• Discovery Capital Management's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 12,445,000 shares worth $426M.
• Discovery Capital Management added most to Amazon in Q1 2016, an estimated $193M increase.
• Discovery Capital Management's biggest Q1 2016 reduction was Alibaba, cutting an estimated $324M.
• Discovery Capital Management fully exited Pfizer in Q1 2016, selling an estimated $471M.
• Discovery Capital Management's ten largest holdings make up 42% of its $6.91B portfolio in Q1 2016.
• Discovery Capital Management opened 43 new positions and closed 37 in Q1 2016.
• Discovery Capital Management's portfolio value fell 18% quarter-over-quarter to $6.91B.

Based on Discovery Capital Management's 13F filing for Q1 2016, filed 16 May 2016.